(±)-{3-[5-fluoro-2-(4-oxo-1,2,3,4-tetrahydronaphthalene-2-carbonyl)-1,2,3,4-tetrahydroisoquinolin-8-yl]-4-methoxyphenyl}acetic acid | 1445885-49-3

• 分子结构分类: 有机化合物 - 有机杂环化合物
• 英文名称: (±)-{3-[5-fluoro-2-(4-oxo-1,2,3,4-tetrahydronaphthalene-2-carbonyl)-1,2,3,4-tetrahydroisoquinolin-8-yl]-4-methoxyphenyl}acetic acid
• 英文别名: 2-[3-[5-fluoro-2-(4-oxo-2,3-dihydro-1H-naphthalene-2-carbonyl)-3,4-dihydro-1H-isoquinolin-8-yl]-4-methoxyphenyl]acetic acid
• CAS: 1445885-49-3
• 化学式: C₂₉H₂₆FNO₅
• 分子量: 487.528
• InChiKey: IYRJKMBOKJQJKV-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.8
• 重原子数：
  36
• 可旋转键数：
  5
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.28
• 拓扑面积：
  83.9
• 氢给体数：
  1
• 氢受体数：
  6

文献信息

• [EN] HETEROCYCLYL DERIVATIVES AND THEIR USE AS PROSTAGLANDIN D2 RECEPTOR MODULATORS<br/>[FR] DÉRIVÉS HÉTÉROCYCLYLE ET LEUR UTILISATION COMME MODULATEURS DE RÉCEPTEURS DE LA PROSTAGLANDINE D2
  申请人：ACTELION PHARMACEUTICALS LTD

  公开号：WO2013093842A1

  公开（公告）日：2013-06-27

  The present invention relates to phenyl-substituted heterocyclyl derivatives of the formula (I) wherein Z, n, m, R1, R2, R3, R4, R5, R6, R7 and R8 are as described in the description and their use as prostaglandin receptor modulators, most particularly as prostaglandin D2 receptor modulators, in the treatment of various prostaglandin-mediated diseases and disorders, to pharmaceutical compositions containing these compounds and to processes for their preparation.

  本发明涉及式(I)的苯基取代杂环基衍生物，其中Z、n、m、R1、R2、R3、R4、R5、R6、R7和R8如描述中所述，并且它们作为前列腺素受体调节剂的用途，尤其作为前列腺素D2受体调节剂，在治疗各种前列腺素介导的疾病和紊乱中的用途，以及含有这些化合物的药物组合物和其制备方法。
• Heterocyclyl Derivatives and their use as Prostaglandin D2 Receptor Modulators
  申请人：Actelion Pharmaceuticals Ltd.

  公开号：US20150252036A1

  公开（公告）日：2015-09-10

  The present invention relates to phenyl-substituted heterocyclyl derivatives of the formula (I), wherein Z, n, m, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 and R 8 are as described in the description and their use as prostaglandin receptor modulators, most particularly as prostaglandin D 2 receptor modulators, in the treatment of various prostaglandin-mediated diseases and disorders, to pharmaceutical compositions containing these compounds and to processes for their preparation.

  本发明涉及公式（I）的苯基取代杂环基衍生物，其中Z，n，m，R1，R2，R3，R4，R5，R6，R7和R8如描述中所述，并且它们作为前列腺素受体调节剂的用途，特别是作为前列腺素D2受体调节剂，在治疗各种前列腺素介导的疾病和疾患中使用，以及包含这些化合物的制药组合物和它们的制备过程。
• HETEROCYCLYL DERIVATIVES AND THEIR USE AS PROSTAGLANDIN D2 RECEPTOR MODULATORS
  申请人：Actelion Pharmaceuticals Ltd.

  公开号：EP2794563A1

  公开（公告）日：2014-10-29
• US9255090B2
  申请人：——

  公开号：US9255090B2

  公开（公告）日：2016-02-09